Global Monoclonal Antibody Therapeutics Market Growth (Status and Outlook) 2022-2028

January 2022 | 103 pages | ID: G7F5F6F089CEEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Monoclonal Antibody Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Monoclonal Antibody Therapeutics market size is USD million in 2022 from USD 111700 million in 2021, with a change of % between 2021 and 2022. The global Monoclonal Antibody Therapeutics market size will reach USD 183700 million in 2028, growing at a CAGR of 7.4% over the analysis period.

The United States Monoclonal Antibody Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Monoclonal Antibody Therapeutics market, reaching US$ million by the year 2028. As for the Europe Monoclonal Antibody Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Monoclonal Antibody Therapeutics players cover Bayer, F. Hoffmann-La Roche, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Humanized Antibody
• Human Mouse Chimeric Antibody

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Cancer
• Autoimmune Diseases
• Infection
• Hematological Diseases
• Ophthalmological Diseases
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Bayer
• F. Hoffmann-La Roche
• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Amgen
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Biogen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Monoclonal Antibody Therapeutics Market Size 2017-2028
  2.1.2 Monoclonal Antibody Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Monoclonal Antibody Therapeutics Segment by Type
  2.2.1 Humanized Antibody
  2.2.2 Human Mouse Chimeric Antibody
2.3 Monoclonal Antibody Therapeutics Market Size by Type
  2.3.1 Monoclonal Antibody Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Monoclonal Antibody Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Autoimmune Diseases
  2.4.3 Infection
  2.4.4 Hematological Diseases
  2.4.5 Ophthalmological Diseases
  2.4.6 Others
2.5 Monoclonal Antibody Therapeutics Market Size by Application
  2.5.1 Monoclonal Antibody Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2022)

3 MONOCLONAL ANTIBODY THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Monoclonal Antibody Therapeutics Market Size Market Share by Players
  3.1.1 Global Monoclonal Antibody Therapeutics Revenue by Players (2020-2022)
  3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Monoclonal Antibody Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MONOCLONAL ANTIBODY THERAPEUTICS BY REGIONS

4.1 Monoclonal Antibody Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Monoclonal Antibody Therapeutics Market Size Growth (2017-2022)
4.3 APAC Monoclonal Antibody Therapeutics Market Size Growth (2017-2022)
4.4 Europe Monoclonal Antibody Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Monoclonal Antibody Therapeutics Market Size by Country (2017-2022)
5.2 Americas Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
5.3 Americas Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Monoclonal Antibody Therapeutics Market Size by Region (2017-2022)
6.2 APAC Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
6.3 APAC Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Monoclonal Antibody Therapeutics by Country (2017-2022)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Monoclonal Antibody Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MONOCLONAL ANTIBODY THERAPEUTICS MARKET FORECAST

10.1 Global Monoclonal Antibody Therapeutics Forecast by Regions (2023-2028)
  10.1.1 Global Monoclonal Antibody Therapeutics Forecast by Regions (2023-2028)
  10.1.2 Americas Monoclonal Antibody Therapeutics Forecast
  10.1.3 APAC Monoclonal Antibody Therapeutics Forecast
  10.1.4 Europe Monoclonal Antibody Therapeutics Forecast
  10.1.5 Middle East & Africa Monoclonal Antibody Therapeutics Forecast
10.2 Americas Monoclonal Antibody Therapeutics Forecast by Country (2023-2028)
  10.2.1 United States Monoclonal Antibody Therapeutics Market Forecast
  10.2.2 Canada Monoclonal Antibody Therapeutics Market Forecast
  10.2.3 Mexico Monoclonal Antibody Therapeutics Market Forecast
  10.2.4 Brazil Monoclonal Antibody Therapeutics Market Forecast
10.3 APAC Monoclonal Antibody Therapeutics Forecast by Region (2023-2028)
  10.3.1 China Monoclonal Antibody Therapeutics Market Forecast
  10.3.2 Japan Monoclonal Antibody Therapeutics Market Forecast
  10.3.3 Korea Monoclonal Antibody Therapeutics Market Forecast
  10.3.4 Southeast Asia Monoclonal Antibody Therapeutics Market Forecast
  10.3.5 India Monoclonal Antibody Therapeutics Market Forecast
  10.3.6 Australia Monoclonal Antibody Therapeutics Market Forecast
10.4 Europe Monoclonal Antibody Therapeutics Forecast by Country (2023-2028)
  10.4.1 Germany Monoclonal Antibody Therapeutics Market Forecast
  10.4.2 France Monoclonal Antibody Therapeutics Market Forecast
  10.4.3 UK Monoclonal Antibody Therapeutics Market Forecast
  10.4.4 Italy Monoclonal Antibody Therapeutics Market Forecast
  10.4.5 Russia Monoclonal Antibody Therapeutics Market Forecast
10.5 Middle East & Africa Monoclonal Antibody Therapeutics Forecast by Region (2023-2028)
  10.5.1 Egypt Monoclonal Antibody Therapeutics Market Forecast
  10.5.2 South Africa Monoclonal Antibody Therapeutics Market Forecast
  10.5.3 Israel Monoclonal Antibody Therapeutics Market Forecast
  10.5.4 Turkey Monoclonal Antibody Therapeutics Market Forecast
  10.5.5 GCC Countries Monoclonal Antibody Therapeutics Market Forecast
10.6 Global Monoclonal Antibody Therapeutics Forecast by Type (2023-2028)
10.7 Global Monoclonal Antibody Therapeutics Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Monoclonal Antibody Therapeutics Product Offered
  11.1.3 Bayer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Bayer Main Business Overview
  11.1.5 Bayer Latest Developments
11.2 F. Hoffmann-La Roche
  11.2.1 F. Hoffmann-La Roche Company Information
  11.2.2 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product Offered
  11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 F. Hoffmann-La Roche Main Business Overview
  11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Monoclonal Antibody Therapeutics Product Offered
  11.3.3 Pfizer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Sanofi
  11.4.1 Sanofi Company Information
  11.4.2 Sanofi Monoclonal Antibody Therapeutics Product Offered
  11.4.3 Sanofi Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Sanofi Main Business Overview
  11.4.5 Sanofi Latest Developments
11.5 GlaxoSmithKline
  11.5.1 GlaxoSmithKline Company Information
  11.5.2 GlaxoSmithKline Monoclonal Antibody Therapeutics Product Offered
  11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 GlaxoSmithKline Main Business Overview
  11.5.5 GlaxoSmithKline Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Monoclonal Antibody Therapeutics Product Offered
  11.6.3 Merck Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Monoclonal Antibody Therapeutics Product Offered
  11.7.3 Novartis Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 AbbVie
  11.8.1 AbbVie Company Information
  11.8.2 AbbVie Monoclonal Antibody Therapeutics Product Offered
  11.8.3 AbbVie Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 AbbVie Main Business Overview
  11.8.5 AbbVie Latest Developments
11.9 Amgen
  11.9.1 Amgen Company Information
  11.9.2 Amgen Monoclonal Antibody Therapeutics Product Offered
  11.9.3 Amgen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Amgen Main Business Overview
  11.9.5 Amgen Latest Developments
11.10 Johnson & Johnson
  11.10.1 Johnson & Johnson Company Information
  11.10.2 Johnson & Johnson Monoclonal Antibody Therapeutics Product Offered
  11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.10.4 Johnson & Johnson Main Business Overview
  11.10.5 Johnson & Johnson Latest Developments

11. BRISTOL-MYERS SQUIBB COMPANY

  11.11.1 Bristol-Myers Squibb Company Company Information
  11.11.2 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product Offered
  11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.11.4 Bristol-Myers Squibb Company Main Business Overview
  11.11.5 Bristol-Myers Squibb Company Latest Developments
11.12 Biogen
  11.12.1 Biogen Company Information
  11.12.2 Biogen Monoclonal Antibody Therapeutics Product Offered
  11.12.3 Biogen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.12.4 Biogen Main Business Overview
  11.12.5 Biogen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Monoclonal Antibody Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Humanized Antibody
Table 3. Major Players of Human Mouse Chimeric Antibody
Table 4. Monoclonal Antibody Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Monoclonal Antibody Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Monoclonal Antibody Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Monoclonal Antibody Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Monoclonal Antibody Therapeutics Key Players Head office and Products Offered
Table 13. Monoclonal Antibody Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Monoclonal Antibody Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Monoclonal Antibody Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Monoclonal Antibody Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Monoclonal Antibody Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Monoclonal Antibody Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Monoclonal Antibody Therapeutics
Table 43. Key Market Challenges & Risks of Monoclonal Antibody Therapeutics
Table 44. Key Industry Trends of Monoclonal Antibody Therapeutics
Table 45. Global Monoclonal Antibody Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Monoclonal Antibody Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Monoclonal Antibody Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Monoclonal Antibody Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Monoclonal Antibody Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Monoclonal Antibody Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bayer Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 52. Bayer Monoclonal Antibody Therapeutics Product Offered
Table 53. Bayer Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. F. Hoffmann-La Roche Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product Offered
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. F. Hoffmann-La Roche Latest Developments
Table 61. Pfizer Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 62. Pfizer Monoclonal Antibody Therapeutics Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Sanofi Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 67. Sanofi Monoclonal Antibody Therapeutics Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sanofi Latest Developments
Table 71. GlaxoSmithKline Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 72. GlaxoSmithKline Monoclonal Antibody Therapeutics Product Offered
Table 73. GlaxoSmithKline Main Business
Table 74. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. GlaxoSmithKline Latest Developments
Table 76. Merck Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 77. Merck Monoclonal Antibody Therapeutics Product Offered
Table 78. Merck Main Business
Table 79. Merck Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Merck Latest Developments
Table 81. Novartis Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 82. Novartis Monoclonal Antibody Therapeutics Product Offered
Table 83. Novartis Main Business
Table 84. Novartis Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Novartis Latest Developments
Table 86. AbbVie Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 87. AbbVie Monoclonal Antibody Therapeutics Product Offered
Table 88. AbbVie Main Business
Table 89. AbbVie Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. AbbVie Latest Developments
Table 91. Amgen Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 92. Amgen Monoclonal Antibody Therapeutics Product Offered
Table 93. Amgen Main Business
Table 94. Amgen Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Amgen Latest Developments
Table 96. Johnson & Johnson Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 97. Johnson & Johnson Monoclonal Antibody Therapeutics Product Offered
Table 98. Johnson & Johnson Main Business
Table 99. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Johnson & Johnson Latest Developments
Table 101. Bristol-Myers Squibb Company Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 102. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product Offered
Table 103. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Bristol-Myers Squibb Company Main Business
Table 105. Bristol-Myers Squibb Company Latest Developments
Table 106. Biogen Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 107. Biogen Monoclonal Antibody Therapeutics Product Offered
Table 108. Biogen Main Business
Table 109. Biogen Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Biogen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Monoclonal Antibody Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monoclonal Antibody Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Monoclonal Antibody Therapeutics Market Size Market Share by Type in 2021
Figure 7. Monoclonal Antibody Therapeutics in Cancer
Figure 8. Global Monoclonal Antibody Therapeutics Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Monoclonal Antibody Therapeutics in Autoimmune Diseases
Figure 10. Global Monoclonal Antibody Therapeutics Market: Autoimmune Diseases (2017-2022) & ($ Millions)
Figure 11. Monoclonal Antibody Therapeutics in Infection
Figure 12. Global Monoclonal Antibody Therapeutics Market: Infection (2017-2022) & ($ Millions)
Figure 13. Monoclonal Antibody Therapeutics in Hematological Diseases
Figure 14. Global Monoclonal Antibody Therapeutics Market: Hematological Diseases (2017-2022) & ($ Millions)
Figure 15. Monoclonal Antibody Therapeutics in Ophthalmological Diseases
Figure 16. Global Monoclonal Antibody Therapeutics Market: Ophthalmological Diseases (2017-2022) & ($ Millions)
Figure 17. Monoclonal Antibody Therapeutics in Others
Figure 18. Global Monoclonal Antibody Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 19. Global Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 20. Global Monoclonal Antibody Therapeutics Revenue Market Share by Player in 2021
Figure 21. Global Monoclonal Antibody Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Monoclonal Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 23. APAC Monoclonal Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 24. Europe Monoclonal Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Monoclonal Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 26. Americas Monoclonal Antibody Therapeutics Value Market Share by Country in 2021
Figure 27. Americas Monoclonal Antibody Therapeutics Consumption Market Share by Type in 2021
Figure 28. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 29. United States Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Region in 2021
Figure 34. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 35. China Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Country in 2021
Figure 42. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Type in 2021
Figure 43. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 44. Germany Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 52. Egypt Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Monoclonal Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. APAC Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Europe Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. United States Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Canada Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. China Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Japan Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Korea Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. India Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Australia Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Germany Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. France Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. UK Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Italy Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Russia Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. Spain Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. Israel Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Monoclonal Antibody Therapeutics Market Size 2023-2028 ($ Millions)